{
  "doc_id": "acbdb9b99b36827b85fe51c4c31f5cc80d6f75d08aa09d556f5d65c13b0edff1",
  "chunk_entities": [
    {
      "chunk_id": "c180e9f7a41331eb112d6b8e1303d581",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "cytokine",
          "context": "Quantification of cytokine concentrations"
        },
        {
          "entity_type": "Compound",
          "entity_name": "IL-6",
          "context": "0.9 pg/ml for IL-6"
        },
        {
          "entity_type": "Compound",
          "entity_name": "MCP-1",
          "context": "1.6 pg/ml for MCP-1"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.9 pg/ml",
          "context": "detection limit was 0.9 pg/ml"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1.6 pg/ml",
          "context": "1.6 pg/ml for MCP-1"
        }
      ]
    },
    {
      "chunk_id": "8307a63ea165b4a9d427b4e616d9cfef",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "Antioxidant capacity",
          "context": "Antioxidant capacity of both extracts"
        },
        {
          "entity_type": "Compound",
          "entity_name": "2,2-diphenyl-1-picrylhydrazyl",
          "context": "using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) inhibition assay"
        },
        {
          "entity_type": "Compound",
          "entity_name": "DPPH",
          "context": "against DPPH radicals"
        },
        {
          "entity_type": "Effect",
          "entity_name": "radical scavenging capacity",
          "context": "assesses radical scavenging capacity against DPPH radicals"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ascorbic acid",
          "context": "with ascorbic acid as the reference standard"
        },
        {
          "entity_type": "Compound",
          "entity_name": "polyphenol",
          "context": "Total polyphenol content was determined"
        },
        {
          "entity_type": "Compound",
          "entity_name": "gallic acid",
          "context": "using gallic acid as standard"
        }
      ]
    },
    {
      "chunk_id": "bfe369da530d39d37d4920f2e638ca28",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "gallic acid",
          "context": "GAE (gallic acid equivalents)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "milligramme",
          "context": "per milligramme"
        }
      ]
    },
    {
      "chunk_id": "7ac27fdf4d0fc003b84ffce9f87e9f3d",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "propidium iodide",
          "context": "Cell viability determined by propidium iodide assay."
        },
        {
          "entity_type": "Compound",
          "entity_name": "PI",
          "context": "% PI negative cells"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "Without LPS (%)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "With LPS (%)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "LPS stimulation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Cell viability",
          "context": "Cell viability determined by propidium iodide assay."
        },
        {
          "entity_type": "Effect",
          "entity_name": "LPS stimulation",
          "context": "with and without LPS stimulation."
        },
        {
          "entity_type": "Effect",
          "entity_name": "reducing viability",
          "context": "LPS stimulation further reducing viability."
        },
        {
          "entity_type": "Effect",
          "entity_name": "decrease in viability",
          "context": "Extracts generally show a slight decrease in viability"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0 mg/ml",
          "context": "Extract Concentration (mg/ml) A 0"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.01 mg/ml",
          "context": "Extract A (0, 0.01, 1 mg/ml)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 mg/ml",
          "context": "Extract A (0, 0.01, 1 mg/ml)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.037 mg/ml",
          "context": "Extract B (0, 0.037, 0.37, 3.7 mg/ml)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.37 mg/ml",
          "context": "Extract B (0, 0.037, 0.37, 3.7 mg/ml)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "3.7 mg/ml",
          "context": "Extract B (0, 0.037, 0.37, 3.7 mg/ml)"
        }
      ]
    },
    {
      "chunk_id": "c0f439b5f3f7155aa8a0a14da5ee683a",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "tyrosinase inhibition",
          "context": "tyrosinase inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "neuroprotection",
          "context": "some degree of neuroprotection"
        }
      ]
    },
    {
      "chunk_id": "149f7c11c050eb136ec584810fbccc22",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Lipopolysaccharide",
          "context": "with/without LPS stimulation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "cytokine",
          "context": "pro-inflammatory cytokine production"
        },
        {
          "entity_type": "Effect",
          "entity_name": "LPS stimulation",
          "context": "with/without LPS stimulation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-inflammatory cytokine production",
          "context": "on pro-inflammatory cytokine production"
        }
      ]
    },
    {
      "chunk_id": "f502f1af5432b678fe2abb92022111dd",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "Acetylcholinesterase",
          "context": "% AChE Inhibition"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Galantamine",
          "context": "Galantamine (%)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Tyrosinase",
          "context": "% TYR Inhibition"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Kojic Acid",
          "context": "Kojic Acid (%)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Acetylcholinesterase",
          "context": "Inhibition of Acetylcholinesterase"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Tyrosinase",
          "context": "and Tyrosinase (b)"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "by Sceletium extracts"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Acetylcholinesterase Inhibition",
          "context": "% AChE Inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Tyrosinase Inhibition",
          "context": "% TYR Inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Inhibition of Acetylcholinesterase",
          "context": "Inhibition of Acetylcholinesterase"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Inhibition of Tyrosinase",
          "context": "Inhibition of Tyrosinase"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "mg/ml",
          "context": "Log concentration (mg/ml)"
        }
      ]
    },
    {
      "chunk_id": "4e35c989e1826ee9ec9b5de775b87549",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "brain injury",
          "context": "respond vigorously to brain injury"
        }
      ]
    },
    {
      "chunk_id": "66677cce409c7d5cf64a033591478a05",
      "entities": [
        {
          "entity_type": "Disease",
          "entity_name": "inflammation",
          "context": "in the context of inflammation"
        },
        {
          "entity_type": "Compound",
          "entity_name": "extract A",
          "context": "extract A clearly limited"
        },
        {
          "entity_type": "Compound",
          "entity_name": "endotoxin",
          "context": "endotoxin-induced cytokine production"
        },
        {
          "entity_type": "Effect",
          "entity_name": "limited cytokine production",
          "context": "clearly limited endotoxin-induced cytokine production"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cytoprotective effects",
          "context": "observed cytoprotective effects of extract A"
        }
      ]
    },
    {
      "chunk_id": "252f4130ee08a06d03a215ccafeacb99",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "antioxidant capacity",
          "context": "Assessment of antioxidant capacity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "polyphenol",
          "context": "total polyphenol content"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Gallic Acid",
          "context": "mg GA equivalents"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "~0.01 mg GA equivalents/mg extract",
          "context": "Extract A (~0.01)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "~0.21 mg GA equivalents/mg extract",
          "context": "Extract B (~0.21)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "DPPH",
          "context": "% DPPH inhibition"
        },
        {
          "entity_type": "Effect",
          "entity_name": "DPPH inhibition",
          "context": "% DPPH inhibition"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Ascorbic acid",
          "context": "and Ascorbic acid"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mitochondrial reductive capacity",
          "context": "mitochondrial reductive capacity"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0 mg/ml",
          "context": "Extract A (0, 0.01, 1 mg/ml)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.01 mg/ml",
          "context": "Extract A (0, 0.01, 1 mg/ml)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "1 mg/ml",
          "context": "Extract A (0, 0.01, 1 mg/ml)"
        },
        {
          "entity_type": "Compound",
          "entity_name": "LPS",
          "context": "with and without LPS"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.037 mg/ml",
          "context": "Extract B (0, 0.037, 0.37, 3.7 mg/ml)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "0.37 mg/ml",
          "context": "Extract B (0, 0.037, 0.37, 3.7 mg/ml)"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "3.7 mg/ml",
          "context": "Extract B (0, 0.037, 0.37, 3.7 mg/ml)"
        }
      ]
    },
    {
      "chunk_id": "a64f98d096b2fbefb9f0a3eebef030d7",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "antioxidant capacity",
          "context": "Assessment of antioxidant capacity"
        },
        {
          "entity_type": "Compound",
          "entity_name": "polyphenol",
          "context": "Total polyphenol content"
        },
        {
          "entity_type": "Compound",
          "entity_name": "gallic acid",
          "context": "expressed as gallic acid (GA) equivalents"
        },
        {
          "entity_type": "Effect",
          "entity_name": "Antioxidant capacity",
          "context": "Antioxidant capacity of extracts"
        },
        {
          "entity_type": "Compound",
          "entity_name": "ascorbic acid",
          "context": "compared to ascorbic acid"
        },
        {
          "entity_type": "Effect",
          "entity_name": "reductive capacity",
          "context": "mitochondrial reductive capacity"
        }
      ]
    },
    {
      "chunk_id": "5800da6f01efc1b8a463261dfd66d2c9",
      "entities": [
        {
          "entity_type": "Compound",
          "entity_name": "extract B",
          "context": "extract B treatment"
        },
        {
          "entity_type": "Effect",
          "entity_name": "cytotoxicity",
          "context": "contributed to cytotoxicity"
        },
        {
          "entity_type": "Disease",
          "entity_name": "inflammatory stressor",
          "context": "in the presence of an inflammatory stressor"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "higher doses",
          "context": "the higher doses of this extract"
        }
      ]
    },
    {
      "chunk_id": "7cb88a889bf138c42347787a55ab64e6",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "antioxidant properties",
          "context": "indicated antioxidant properties of extract B"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "highest dose",
          "context": "exposure to the highest dose of this extract"
        },
        {
          "entity_type": "Compound",
          "entity_name": "Bacterial LPS",
          "context": "Bacterial LPS exposure caused significant mitotoxicity"
        },
        {
          "entity_type": "Effect",
          "entity_name": "mitotoxicity",
          "context": "caused significant mitotoxicity"
        },
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "addition of either Sceletium extract"
        },
        {
          "entity_type": "Disease",
          "entity_name": "low-grade inflammation",
          "context": "settings of low-grade inflammation"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic disease",
          "context": "such as chronic disease"
        },
        {
          "entity_type": "Disease",
          "entity_name": "high-grade inflammation",
          "context": "acute bout of high-grade inflammation"
        }
      ]
    },
    {
      "chunk_id": "4ca6102d74ead5450c184510828a72a1",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium tortuosum",
          "context": "Sceletium tortuosum extract"
        },
        {
          "entity_type": "Effect",
          "entity_name": "beneficial effects",
          "context": "exert more beneficial effects"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "broad range of doses",
          "context": "at a broad range of doses"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic disease",
          "context": "setting of chronic disease"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic disease-associated neurodegeneration",
          "context": "prevention of chronic disease-associated neurodegeneration"
        },
        {
          "entity_type": "Disease",
          "entity_name": "oxidative stress",
          "context": "where oxidative stress is both an etiological and comorbid factor"
        },
        {
          "entity_type": "Effect",
          "entity_name": "antioxidant",
          "context": "much more potent antioxidant product"
        },
        {
          "entity_type": "Dosage",
          "entity_name": "specific, low doses",
          "context": "administered at specific, low doses"
        },
        {
          "entity_type": "Effect",
          "entity_name": "pro-oxidant damage",
          "context": "minimising undesired pro-oxidant damage"
        }
      ]
    },
    {
      "chunk_id": "9687d152d9df0565049721731cdf629c",
      "entities": [
        {
          "entity_type": "Effect",
          "entity_name": "inflammation limitation",
          "context": "limiting inflammation"
        },
        {
          "entity_type": "Effect",
          "entity_name": "oxidative stress reduction",
          "context": "limiting ... oxidative stress"
        },
        {
          "entity_type": "Effect",
          "entity_name": "rate-limiting effect",
          "context": "achieve a rate-limiting effect"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic disease",
          "context": "effect on chronic disease"
        }
      ]
    },
    {
      "chunk_id": "586560bdaca19c12c589752a90d4ee5b",
      "entities": [
        {
          "entity_type": "Plant",
          "entity_name": "Sceletium",
          "context": "effects of Sceletium extracts"
        },
        {
          "entity_type": "Compound",
          "entity_name": "alkaloids",
          "context": "its isolated pure alkaloids"
        },
        {
          "entity_type": "Disease",
          "entity_name": "chronic lifestyle diseases",
          "context": "setting of chronic lifestyle diseases"
        },
        {
          "entity_type": "Disease",
          "entity_name": "type 2 diabetes",
          "context": "such as type 2 and type 3 diabetes"
        },
        {
          "entity_type": "Disease",
          "entity_name": "type 3 diabetes",
          "context": "such as type 2 and type 3 diabetes"
        }
      ]
    }
  ],
  "total_entities": 105,
  "extraction_date": "2026-02-01T08:46:19.508554+00:00"
}